Quantum Biopharma (QNTM) Return on Capital Employed (2024 - 2026)
Quantum Biopharma recorded quarterly Return on Capital Employed of 450.31% in Q1 2026, up 294.18% quarter-over-quarter from 231.9% in Q4 2025, and up 68255.0% year-over-year from N/an in Q1 2025.
Quantum Biopharma's Return on Capital Employed history runs 3 years deep, the most recent figure standing at 450.31% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 68255.0% year-over-year to 450.31%; the TTM figure through Mar 2026 stood at 450.31% (up 68255.0% YoY), while the FY2025 annual figure was 189.34%, down 3737.0% from the prior year.
- Return on Capital Employed came in at 450.31% for Q1 2026 at Quantum Biopharma, up from 231.9% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 450.31% in Q1 2026 to a low of 791.35% in Q2 2025.
- A 3-year average of 182.72% and a median of 208.91% in 2025 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 12670 bps in 2025 and surged 68255 bps in 2026, its largest moves.
- Quantum Biopharma's Return on Capital Employed stood at 105.2% in 2024, then plunged by 120 bps to 231.9% in 2025, then surged by 294 bps to 450.31% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 450.31%, 231.9%, and 185.93% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -21.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 450.31% |
| Dec 31, 2025 | -231.90% |
| Sep 30, 2025 | -185.93% |
| Jun 30, 2025 | -791.35% |
| Mar 31, 2025 | -232.25% |
| Dec 31, 2024 | -105.20% |